| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Naringenin | Breast Cancer | 21 | PM | 37480513 | 📋 | Naringenin in combination with quercetin/fisetin shows synergistic anti-proliferative and migration reduction effects in breast cancer cell lines |
| Naringenin | Breast Cancer | 20 | PM | 36978836 | 📋 | Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer |
| Naringenin | Breast Cancer | 19 | PM | 36014942 | 📋 | Synergism Potentiates Oxidative Antiproliferative Effects of Naringenin and Quercetin in MCF-7 Breast Cancer Cells |
| Naringenin | Breast Cancer | 18 | PM | 35718080 | 📋 | Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway |
| Naringenin | Breast Cancer | 17 | PM | 35606804 | 📋 | Naringenin and cryptotanshinone shift the immune response towards Th1 and modulate T regulatory cells via JAK2/STAT3 pathway in breast cancer |
| Naringenin | Breast Cancer | 16 | PM | 35087512 | 📋 | Naringenin Regulates FKBP4/NR3C1/NRF2 Axis in Autophagy and Proliferation of Breast Cancer and Differentiation and Maturation of Dendritic Cell |
| Naringenin | Breast Cancer | 15 | PM | 34817344 | 📋 | Naringenin inhibits human breast cancer cells (MDA-MB-231) by inducing programmed cell death, caspase stimulation, G2/M phase cell cycle arrest and suppresses cancer metastasis |
| Naringenin | Breast Cancer | 14 | PM | 34737698 | 📋 | Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells |
| Naringenin | Breast Cancer | 13 | PM | 34125254 | 📋 | Enhanced antitumor activity of doxorubicin by naringenin and metformin in breast carcinoma: an experimental study |
| Naringenin | Breast Cancer | 12 | PM | 33782546 | 📋 | Anti-estrogenic and anti-aromatase activities of citrus peels major compounds in breast cancer |
| Naringenin | Breast Cancer | 11 | PM | 33680016 | 📋 | Naringenin Enhances the Anti-Cancer Effect of Cyclophosphamide against MDA-MB-231 Breast Cancer Cells Via Targeting the STAT3 Signaling Pathway |
| Naringenin | Breast Cancer | 10 | PM | 33603536 | 📋 | Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies |
| Naringenin | Breast Cancer | 9 | PM | 33157041 | 📋 | Combining naringenin and metformin with doxorubicin enhances anticancer activity against triple-negative breast cancer in vitro and in vivo |
| Naringenin | Breast Cancer | 8 | PM | 30941613 | 📋 | Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways |
| Naringenin | Breast Cancer | 6 | PM | 30655887 | 📋 | Naringenin has a chemoprotective effect in MDA-MB-231 breast cancer cells via inhibition of caspase-3 and -9 activities |
| Naringenin | Breast Cancer | 3 | PM | 30153467 | 📋 | Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes |
| Naringenin | Breast Cancer | 2 | PM | 29968480 | 📋 | Augmented anticancer activity of naringenin-loaded TPGS polymeric nanosuspension for drug resistive MCF-7 human breast cancer cells |
| Naringenin | Breast Cancer | 1 | PM | 28370954 | 📋 | Citrus flavonoid naringenin reduces mammary tumor cell viability, adipose mass, and adipose inflammation in obese ovariectomized mice |
| Naringenin | Breast Cancer | 4 | PM | 27449398 | 📋 | Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors |
| Naringenin | Breast Cancer | 5 | PM | 26226761 | 📋 | [Study on effect of naringenin in inhibiting migration and invasion of breast cancer cells and its molecular mechanism] |
| Naringenin | Breast Cancer | 7 | PM | 26074733 | 📋 | Growth inhibitory and chemo-sensitization effects of naringenin, a natural flavanone purified from Thymus vulgaris, on human breast and colorectal cancer |
| Naringenin | Cervical Cancer | 1 | PM | 38253629 | 📋 | Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer |
| Naringenin | Choriocarcinoma | 1 | PM | 30466984 | 📋 | Naringenin suppresses growth of human placental choriocarcinoma via reactive oxygen species-mediated P38 and JNK MAPK pathways |
| Naringenin | Endometrial Hyperplasia | 1 | PM | 35143137 | 📋 | Naringenin and morin reduces insulin resistance and endometrial hyperplasia in the rat model of polycystic ovarian syndrome through enhancement of inflammation and autophagic apoptosis |
| Naringenin | Endometriosis | 2 | PM | 31252288 | 📋 | Naringenin ameliorates progression of endometriosis by modulating Nrf2/Keap1/HO1 axis and inducing apoptosis in rats |
| Naringenin | Endometriosis | 1 | PM | 29121349 | 📋 | Naringenin induces mitochondria-mediated apoptosis and endoplasmic reticulum stress by regulating MAPK and AKT signal transduction pathways in endometriosis cells |
| Naringenin | Gestational Diabetes | 3 | PM | 32814161 | 📋 | Defective insulin receptor signaling in patients with gestational diabetes is related to dysregulated miR-140 which can be improved by naringenin |
| Naringenin | Gestational Diabetes | 2 | PM | 32021351 | 📋 | The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy |
| Naringenin | Gestational Diabetes | 1 | PM | 31591391 | 📋 | Naringenin improves insulin sensitivity in gestational diabetes mellitus mice through AMPK |
| Naringenin | Gestational Diabetes | 4 | PM | 31343820 | 📋 | Anti-Diabetic, Anti-Inflammatory, and Anti-Oxidant Effects of Naringenin in an In Vitro Human Model and an In Vivo Murine Model of Gestational Diabetes Mellitus |
| Naringenin | Gestational Hypertension | 1 | PM | 34117816 | 📋 | Naringenin prevents pregnancy-induced hypertension via suppression of JAK/STAT3 signaling pathway in mice |
| Naringenin | Ovarian Cancer | 3 | PM | 38116560 | 📋 | Co-treatment of Naringenin and Ketoprofen-RGD Suppresses Cell Proliferation via Calmodulin/PDE/cAMP/PKA Axis Pathway in Leukemia and Ovarian Cancer Cells |
| Naringenin | Ovarian Cancer | 2 | PM | 36029647 | 📋 | Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota |
| Naringenin | Ovarian Cancer | 1 | PM | 35184257 | 📋 | BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression |
| Naringenin | Polycystic Ovary Syndrome | 5 | PM | 38009056 | 📋 | Naringenin alleviates the excessive lipid deposition of polycystic ovary syndrome rats and insulin-resistant adipocytes by promoting PKGIα |
| Naringenin | Polycystic Ovary Syndrome | 4 | PM | 37165686 | 📋 | Naringenin improves ovarian health by reducing the serum androgen and eliminating follicular cysts in letrozole-induced polycystic ovary syndrome in the Sprague Dawley rats |
| Naringenin | Polycystic Ovary Syndrome | 3 | PM | 35724506 | 📋 | Naringenin regulates gut microbiota and SIRT1/ PGC-1ɑ signaling pathway in rats with letrozole-induced polycystic ovary syndrome |
| Naringenin | Polycystic Ovary Syndrome | 2 | PM | 35143137 | 📋 | Naringenin and morin reduces insulin resistance and endometrial hyperplasia in the rat model of polycystic ovarian syndrome through enhancement of inflammation and autophagic apoptosis |
| Naringenin | Pregnancy Complications | 1 | PM | 23475986 | 📋 | Dietary phytophenols curcumin, naringenin and apigenin reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and myometrium |
